400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / GPCR/G Protein / Cannabinoid Receptor / GW842166X
CAS No.: 666260-75-9
Synonyms: 842166X;842166;GW-842166
GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00444769 | Pain | Phase 2 | Completed | - | Germany ... more >> GSK Investigational Site Hamburg, Germany, 22769 Italy GSK Investigational Site Verona, Veneto, Italy, 37134 United Kingdom GSK Investigational Site London, United Kingdom, WC1X 8LD Collapse << |
NCT00511524 | Pain, Inflammatory | Phase 1 | Completed | - | Sweden ... more >> GSK Investigational Site Uppsala, Sweden, SE-753 23 Collapse << |
NCT00554762 | Healthy Subjects | Phase 1 | Withdrawn(Compound terminated) | March 2008 | - |
实验方案
技术信息
CAS号 | 666260-75-9 | 储存条件 |
|
|
分子式 | C18H17Cl2F3N4O2 | 运输 | 蓝冰 | |
分子量 | 449.25 | 别名 | 842166X;842166;GW-842166 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00444769 | Pain | Phase 2 | Completed | - | Germany ... more >> GSK Investigational Site Hamburg, Germany, 22769 Italy GSK Investigational Site Verona, Veneto, Italy, 37134 United Kingdom GSK Investigational Site London, United Kingdom, WC1X 8LD Collapse << |
NCT00511524 | Pain, Inflammatory | Phase 1 | Completed | - | Sweden ... more >> GSK Investigational Site Uppsala, Sweden, SE-753 23 Collapse << |
NCT00554762 | Healthy Subjects | Phase 1 | Withdrawn(Compound terminated) | March 2008 | - |
NCT00536497 | Healthy Subjects | Phase 1 | Withdrawn(Compound terminated) | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网